Cargando…
The Sphingolipid Biosynthetic Pathway Is a Potential Target for Chemotherapy against Chagas Disease
The protozoan parasite Trypanosoma cruzi is the causative agent of human Chagas disease, for which there currently is no cure. The life cycle of T. cruzi is complex, including an extracellular phase in the triatomine insect vector and an obligatory intracellular stage inside the vertebrate host. The...
Autores principales: | Koeller, Carolina Macedo, Heise, Norton |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
SAGE-Hindawi Access to Research
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3092604/ https://www.ncbi.nlm.nih.gov/pubmed/21603271 http://dx.doi.org/10.4061/2011/648159 |
Ejemplares similares
-
Venom alkaloids against Chagas disease parasite: search for effective therapies
por: Silva, Rafael C. M. Costa, et al.
Publicado: (2020) -
The sphingolipid biosynthetic enzyme Sphingolipid delta8 desaturase is important for chilling resistance of tomato
por: Zhou, Ying, et al.
Publicado: (2016) -
Sphingolipids as Potential Therapeutic Targets against Enveloped Human RNA Viruses
por: Yager, Eric J., et al.
Publicado: (2019) -
Sphingolipid and Ceramide Homeostasis: Potential Therapeutic Targets
por: Young, Simon A., et al.
Publicado: (2012) -
Potential therapeutic targets for atherosclerosis in sphingolipid metabolism
por: Yu, Zemou, et al.
Publicado: (2019)